Oncology Nursing News®

Immuno-Oncology

Utilizing Treatment Free Survival as an Endpoint in Research

Utilizing Treatment Free Survival as an Endpoint in Research

BY MEREDITH M. REGAN, SCD

Expert Discusses Studying irAEs in Patients With ICC

Expert Discusses Studying irAEs in Patients With ICC

BY SARAH ABOU ALAIWI, MD

Providing Immunotherapy Treatment, Support, and Education Under One Roof Proves Beneficial For Patients

Providing Immunotherapy Treatment, Support, and Education Under One Roof Proves Beneficial For Patients

BY CONOR KILLMURRAY

Immunotherapy in Small Cell Lung Cancer Enters a New Era

Immunotherapy in Small Cell Lung Cancer Enters a New Era

BY JESSICA HERGERT

Expanding Treatment in The Neoadjuvant Setting

Expanding Treatment in The Neoadjuvant Setting

BY ASHISH SAXENA, MD, PHD

Frontline Immunotherapy in Patients with Advanced Nonsquamous NSCLC Shows Promise

Frontline Immunotherapy in Patients with Advanced Nonsquamous NSCLC Shows Promise

BY CAROLINE SEYMOUR

Chemotherapy and Immunotherapy Combinations are The Future of NSCLC Treatment

Chemotherapy and Immunotherapy Combinations are The Future of NSCLC Treatment

BY CATHERINE SHU, MD

Helping Patients with Lung Cancer Understand Their Treatment Options

Helping Patients with Lung Cancer Understand Their Treatment Options

BY CONOR KILLMURRAY

FDA Grants Priority Review For Nivolumab/Ipilimumab Combination In Advanced HCC

FDA Grants Priority Review For Nivolumab/Ipilimumab Combination In Advanced HCC

BY GINA COLUMBUS

KATE2 Study Misses Endpoint, Appears Promising for HER2+, PD-L1-Expressing Breast Tumors

KATE2 Study Misses Endpoint, Appears Promising for HER2+, PD-L1-Expressing Breast Tumors

BY CONOR KILLMURRAY

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.